Document Detail


Safety of medications prescribed before and during early pregnancy in a cohort of 81,975 mothers from the UK General Practice Research Database.
MedLine Citation:
PMID:  16767799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: To demonstrate a linkage methodology for mother and baby automated medical records, and describe frequency, type, and pregnancy risk level of medications prescribed during pregnancy in a GPRD cohort, 1991-1999. METHODS: We linked records using a two-stage algorithm and selected pairs with > or = 7 months prenatal records and > or = 2 records in baby's first year of life. Periods of interest were: 90 days prior to a woman's earliest identified pregnancy record (Period I), and this record plus 70 days (Period II, approximate early pregnancy). Medications were classified using the British National Formulary and US Food and Drug Administration Pregnancy Risk Categories. RESULTS: We achieved over 80% record linkage and defined a cohort of 81,975. Sixty-five per cent of mothers had > or = 1 prescription during both periods combined. Most frequent medications in Period I were anti-bacterial, contraceptive, topical steroid, and bronchodilator. In Period II, they were folic acid, anti-bacterial, antacid, and gynecological anti-infective. In Period I, 4% were FDA category A (considered safest), 34% B, and 49% C and D combined. By Period II, prescription of category A medications increased (folic acid, iron) while other categories declined. Category X medications, with potential teratogenic risk that outweighs maternal benefit, were prescribed to 5714 (7%) women in Period I, and 501 (0.6%) women in Period II (46% progesterone). CONCLUSIONS: One in every 164 women received a category X prescription in early pregnancy. The visit when pregnancy is first medically recognized represents an opportunity to review prescribed medications in light of contraindication and/or fetal risk.
Authors:
Janet R Hardy; Brian P Leaderer; Theodore R Holford; Gillian C Hall; Michael B Bracken
Related Documents :
8129259 - Risk assessment of drug use in pregnancy: prevention of birth defects.
17181429 - Fetal risks related to the treatment of multiple sclerosis during pregnancy and breastf...
16199349 - The use of levomepromazine in hyperemesis gravidarum resistant to drug therapy--a case ...
19365629 - Prescription of drugs during pregnancy: a study using efemeris, the new french database.
6115739 - The treatment of hypertension in pregnancy.
17300719 - The safety of artemisinins during pregnancy: a pressing question.
9511189 - Fetal lung volumetry by three-dimensional ultrasound.
16864949 - Clinical manifestations and outcomes of parvovirus b19 infection during pregnancy in ja...
2788219 - Modulation of the immunosuppressive activities by blastocoelic fluid during rabbit preg...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pharmacoepidemiology and drug safety     Volume:  15     ISSN:  1053-8569     ISO Abbreviation:  Pharmacoepidemiol Drug Saf     Publication Date:  2006 Aug 
Date Detail:
Created Date:  2006-08-23     Completed Date:  2007-01-10     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  9208369     Medline TA:  Pharmacoepidemiol Drug Saf     Country:  England    
Other Details:
Languages:  eng     Pagination:  555-64     Citation Subset:  IM    
Copyright Information:
Copyright 2006 John Wiley & Sons, Ltd.
Affiliation:
Division of Preventive and Behavioral Medicine, University of Massachusetts School of Medicine, Worcester, MA 01655, USA. janet.hardy@umassmed.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Databases, Factual
Drug Prescriptions / statistics & numerical data*
Drug Therapy / classification,  contraindications,  statistics & numerical data*
Drug Utilization / statistics & numerical data*
Female
Great Britain
Humans
Medical Records Systems, Computerized
Mothers
Pregnancy / statistics & numerical data*
Teratogens
Chemical
Reg. No./Substance:
0/Teratogens

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.).
Next Document:  Ignoring endotoxin.